Showing results (701-710 of 1,018) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|November 1, 2024
Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with AzacitidineAthanasios Tasis, Nikos E Papaioannou, Maria Grigoriou, et al.
Cancer Research Communications|October 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing TumorsMarc Lopez, Emerence Crompot, Emmanuelle Josselin, et al.
Cancer Research Communications|May 12, 2026
CD4+ T-cells sensitize quasi-mesenchymal breast tumors lacking CD73 to anti-CTLA4 immune checkpoint blockade therapyShiney Chandraganti, Caitlyn Sams, Sarthak Sahoo, et al.
Cancer Research Communications|May 21, 2026
Increased glucose availability sensitizes pancreatic cancer to macrophage-targeting immunotherapiesJonathan J Hue, Mehrdad Zarei, Priyashree Sunita, et al.
Cancer Research Communications|May 21, 2026
Chronic high-fat diet does not alter overall cancer incidence in Trp53R270H/+ miceIlaria Panzeri, Zachary B Madaj, Luca Fagnocchi, et al.
Cancer Research Communications|March 24, 2026
Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United StatesChia Jie Tan, Connor Willis, Timothy Bell, et al.
Cancer Research Communications|May 8, 2026
TNBC spatial transcriptomic analysis across clinical states reveals subtype-specific networks and immunosuppressive nichesFengyuan Huang, Nitish Kunte, Himani Khurana, et al.
Cancer Research Communications|March 25, 2026
Mapping genomic heterogeneity in paediatric and adolescent-young adult sarcomas: insights from the Italian SAR-GEN2016 and SAR-GEN_ITA prospective multicenter trialsElisa Tirtei, Valeria Difilippo, Federico Divincenzo, et al.
Cancer Research Communications|March 2, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine BioavailabilityNadeen Anabtawi, Thomas Drabison, Alexander F Ham, et al.
Cancer Research Communications|February 26, 2026
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 StudyMariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca, et al.
Pageof 102